Roundup: Singapore’s VUNO AI fund analysis software OKs and more summary information
Singapore removes VANO AI software for fund analysis
South Korean medical AI company VUNO recently received medical device certification from the Health Sciences Authority of Singapore for its AI-based fund analysis software.
The VUNO Med-Fundus AI analyzes images of the orbit, which is the back of the eye, to provide the necessary findings for the diagnosis of retinal diseases. It can detect the location of lesions indicating diseases, such as diabetic retinopathy, macular disease and glaucoma, within seconds.
Through this certification, VUNO is able to penetrate the growing medical device market in Singapore, which is expected to reach a value of USD 1 billion by 2024, growing at a CAGR of 8.7% from 2014. 2019.
Taiwan-based Point Robotics gets 510(k) for its surgical robot system
Point Robotics, a manufacturer of surgical robots in Taiwan, has received a 510(k) license from the US Food and Drug Administration for its robotic-assisted integrated surgical system for fusion surgeries. Spine.
The POINT Kinguide robotic-assisted surgery system combines image-guided navigation and hand-held drilling to streamline procedural workflows with precision, stability, and reproducibility of motion. of robots.
According to the company, what sets it apart from similar systems is its parallel-action mechanism that allows it to expand indications for more complex disc herniation surgery.
After US clearance, Point Robotics is preparing for CE marking in Europe and registration in China, expanding its presence in international markets.
SC Juang CEO said: “We aim to promote the availability and affordability of robotics for spine surgery that is not constrained by today’s technology to treat a wide range of patients with more spinal diseases”.
Mental health startup Lissun gets $1 million in pre-launch funding
Indian mental health platform Lissun has raised $1 million in a pre-seed funding round led by IvyCap Ventures. The round also featured We Founder Circle, Supermorpheous, and other marquee angel investors.
The startup uses a unique “B2H2C” approach – reaching consumers through partnerships with healthcare organizations – in providing a comprehensive mental health solution. It has relationships with more than 70 healthcare organizations in 17 cities in India.
Based on a press statement, Lissun’s technology is applied to high-stress use cases in six healthcare categories, such as infertility, rehabilitation, kidney and cancer. mail, among others. “The fact that mental and emotional problems can be an underlying problem in many medical cases is what we have identified and are proactively explaining,” said co-founder, Dr. Singh explained.
Through the new investment, Lissun aims to strengthen the backbone of the technology and further develop it to provide a seamless user experience. Furthermore, it plans to expand to 25 cities, as well as include five other therapeutic categories.
India reuses COVID-19 apps
The Indian government plans to reuse two key mobile apps to track COVID-19 cases in the country.
A news report quoted Dr Ram Sewak Sharma, CEO of the National Health Service, as saying that they plan to reuse the contact tracing app Aarogya Setu as a national health app while the Covid platform Vaccine Intelligent Network (CoWIN) will be reused for the national immunization program and a health management information system for small doctors.